188 related articles for article (PubMed ID: 33562815)
21. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
22. The class V myosin motor, myosin 5c, localizes to mature secretory vesicles and facilitates exocytosis in lacrimal acini.
Marchelletta RR; Jacobs DT; Schechter JE; Cheney RE; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2008 Jul; 295(1):C13-28. PubMed ID: 18434623
[TBL] [Abstract][Full Text] [Related]
23. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
24. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
25. Salivary and Lacrimal Gland Alterations of the Epidermal Fatty Acid-Binding Protein (E-FABP) in Non-Obese Diabetic Mice.
Dogru M; Kojima T; Simsek C; Nagata T; Tsubota K
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408851
[TBL] [Abstract][Full Text] [Related]
26. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
27. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.
Schenke-Layland K; Xie J; Angelis E; Starcher B; Wu K; Riemann I; MacLellan WR; Hamm-Alvarez SF
Matrix Biol; 2008 Jan; 27(1):53-66. PubMed ID: 17689946
[TBL] [Abstract][Full Text] [Related]
28. Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.
Guo H; Ju Y; Choi M; Edman MC; Louie SG; Hamm-Alvarez SF; MacKay JA
Biomaterials; 2022 Apr; 283():121441. PubMed ID: 35306230
[TBL] [Abstract][Full Text] [Related]
29. Normal and Sjogren's syndrome models of the murine lacrimal gland studied at single-cell resolution.
Rattner A; Heng JS; Winer BL; Goff LA; Nathans J
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2311983120. PubMed ID: 37812717
[TBL] [Abstract][Full Text] [Related]
30. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
[TBL] [Abstract][Full Text] [Related]
31. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.
Chaly Y; Barr JY; Sullivan DA; Thomas HE; Brodnicki TC; Lieberman SM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347820
[TBL] [Abstract][Full Text] [Related]
32. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
[TBL] [Abstract][Full Text] [Related]
33. Transduced viral IL-10 is exocytosed from lacrimal acinar secretory vesicles in a myosin-dependent manner in response to carbachol.
Xie J; Marchelletta RR; Thomas PB; Jacobs DT; Yarber FA; Cheney RE; Hamm-Alvarez SF; Trousdale MD
Exp Eye Res; 2009 Mar; 88(3):467-78. PubMed ID: 19056381
[TBL] [Abstract][Full Text] [Related]
34. Direct interaction between Rab3D and the polymeric immunoglobulin receptor and trafficking through regulated secretory vesicles in lacrimal gland acinar cells.
Evans E; Zhang W; Jerdeva G; Chen CY; Chen X; Hamm-Alvarez SF; Okamoto CT
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C662-74. PubMed ID: 18171724
[TBL] [Abstract][Full Text] [Related]
35. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
36. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
37. Rab27A Is Present in Mouse Pancreatic Acinar Cells and Is Required for Digestive Enzyme Secretion.
Hou Y; Ernst SA; Stuenkel EL; Lentz SI; Williams JA
PLoS One; 2015; 10(5):e0125596. PubMed ID: 25951179
[TBL] [Abstract][Full Text] [Related]
38. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models.
Hawley D; Tang X; Zyrianova T; Shah M; Janga S; Letourneau A; Schicht M; Paulsen F; Hamm-Alvarez S; Makarenkova HP; Zoukhri D
Sci Rep; 2018 Jul; 8(1):9919. PubMed ID: 29967327
[TBL] [Abstract][Full Text] [Related]
39. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
[TBL] [Abstract][Full Text] [Related]
40. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.
Li L; Jasmer KJ; Camden JM; Woods LT; Martin AL; Yang Y; Layton M; Petris MJ; Baker OJ; Weisman GA; Petris CK
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):18. PubMed ID: 35727180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
